Pricing Zolgensma—The World’s Most Expensive Drug
Department Pricing and Valuation, A2M, Amsterdam, The Netherlands
J. Mark. Access Health Policy 2022, 10(1), 2022353; https://doi.org/10.1080/20016689.2021.2022353
Submission received: 9 August 2021
/
Revised: 16 December 2021
/
Accepted: 21 December 2021
/
Published: 29 December 2022
Abstract
A heated discussion has recently broken out in Europe about the price of Zolgensma, ‘the most expensive drug ever’ [...]
Keywords:
Price valuation reimbursement; orphan disease
Share and Cite
MDPI and ACS Style
Nuijten, M. Pricing Zolgensma—The World’s Most Expensive Drug. J. Mark. Access Health Policy 2022, 10, 2022353. https://doi.org/10.1080/20016689.2021.2022353
AMA Style
Nuijten M. Pricing Zolgensma—The World’s Most Expensive Drug. Journal of Market Access & Health Policy. 2022; 10(1):2022353. https://doi.org/10.1080/20016689.2021.2022353
Chicago/Turabian StyleNuijten, Mark. 2022. "Pricing Zolgensma—The World’s Most Expensive Drug" Journal of Market Access & Health Policy 10, no. 1: 2022353. https://doi.org/10.1080/20016689.2021.2022353
